The abstract is read at the publisher; the summary is JClub's.
In treatment-naïve Guillain-Barré syndrome, CSF shows compartmental enrichment of Th1-polarized CD4+ and activated/resident-memory CD8+ T cells plus macrophages, exceeding healthy controls.
- Why it matters: The cellular basis of GBS and how IVIg reshapes immune responses is unclear, limiting biomarker and therapeutic targeting.
- What they did: In a prospective observational cohort, single-cell RNA-seq with paired TCR sequencing was performed on peripheral blood and CSF before and after IVIg in 9 and 8 patients (post-treatment: 6 blood, 3 CSF), compared with published healthy control datasets.
- The result: IVIg produced minimal peripheral blood changes but more substantial CSF shifts, including reduced Th1-associated and activated effector-memory states, increased Th2 and regulatory T cells, and repertoire changes, with pathogen-associated expanded clonotypes and convergent groups detected in six patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.